Cardiome Pharma Revenue 2006-2019 | CORV

Cardiome Pharma revenue from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Cardiome Pharma Annual Revenue
(Millions of US $)
2018 $29
2017 $24
2016 $25
2015 $21
2014 $30
2013 $5
2012 $1
2011 $2
2010 $66
2009 $48
2008 $2
2007 $5
2006 $18
2005 $13
Cardiome Pharma Quarterly Revenue
(Millions of US $)
Q1 2019 $7
Q4 2018 $9
Q3 2018 $7
Q2 2018 $6
Q1 2018 $7
Q4 2017 $7
Q3 2017 $6
Q2 2017 $6
Q1 2017 $5
Q4 2016 $7
Q3 2016 $5
Q2 2016 $6
Q1 2016 $7
Q4 2015 $5
Q3 2015 $5
Q2 2015 $6
Q1 2015 $5
Q4 2014 $7
Q3 2014 $8
Q2 2014 $8
Q1 2014 $8
Q4 2013 $4
Q3 2013 $0
Q2 2013 $0
Q1 2013 $0
Q4 2012 $0
Q3 2012 $0
Q2 2012 $0
Q1 2012 $0
Q4 2011 $0
Q3 2011 $0
Q2 2011 $0
Q1 2011 $0
Q4 2010 $0
Q3 2010 $30
Q2 2010 $12
Q1 2010 $23
Q4 2009 $23
Q3 2009 $19
Q2 2009 $7
Q1 2009 $0
Q4 2008 $0
Q3 2008 $0
Q2 2008 $0
Q1 2008 $0
Q4 2007 $1
Q3 2007 $1
Q2 2007 $1
Q1 2007 $1
Q4 2006 $11
Q3 2006 $2
Q2 2006 $2
Q1 2006 $3
Q4 2005 $3
Q3 2005 $4
Q2 2005 $3
Q1 2005 $4
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.080B $0.029B
Correvio Pharma Corp. operates as a pharmaceutical company. It develops and discovers cardiovascular drugs for the treatment of atrial arrhythmia, congestive heart failure and bacterial skin infections. The company's product portfolio includes BRINAVESS(R), AGGRASTAT(R), ESMOCARD(R), ESMOCARDLYO(R), EXEMBOL(R) and XYDALBA(TM). Correvio Pharma Corp., formerly known as Correvio Pharma Corp., is based in Vancouver, Canada.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $54.361B 34.73
Astellas Pharma (ALPMY) Japan $28.294B 13.87
Takeda Pharmaceutical (TAK) Japan $28.107B 8.25
Eisai (ESALY) Japan $16.062B 27.62
UCB SA (UCBJF) Belgium $15.866B 0.00
Grifols, S.A (GRFS) Spain $14.831B 18.76
Merck (MKGAF) Germany $13.435B 18.33
IPSEN SA ADR (IPSEY) France $10.783B 0.00
Sage Therapeutics (SAGE) United States $9.586B 0.00
Ionis Pharmaceuticals (IONS) United States $9.522B 20.82
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Neurocrine Biosciences (NBIX) United States $7.992B 0.00
Catalent (CTLT) United States $7.866B 31.57
Jazz Pharmaceuticals (JAZZ) Ireland $7.641B 10.48
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
Nektar Therapeutics (NKTR) United States $5.789B 9.43
STADA ARZNEIMI (STDAF) Germany $5.634B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.420B 0.00
Orion OYJ (ORINY) Finland $5.275B 24.34
Hypermarcas (HYPMY) Brazil $4.894B 17.20
Evotec AG (EVTCY) Germany $4.308B 46.24
Tilray (TLRY) Canada $4.300B 0.00
FibroGen (FGEN) United States $4.000B 0.00
United Therapeutics (UTHR) United States $3.338B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.172B 11.39
Arrowhead Pharmaceuticals (ARWR) United States $2.636B 397.14
PTC Therapeutics (PTCT) United States $2.549B 0.00
Xencor (XNCR) United States $2.481B 67.72
Zogenix (ZGNX) United States $2.005B 0.00
Portola Pharmaceuticals (PTLA) United States $1.776B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.687B 81.72
Enanta Pharmaceuticals (ENTA) United States $1.609B 21.99
Ironwood Pharmaceuticals (IRWD) United States $1.607B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
Heron Therapeutics (HRTX) United States $1.448B 0.00
USANA Health Sciences (USNA) United States $1.388B 12.06
Corcept Therapeutics (CORT) United States $1.223B 17.46
ArQule (ARQL) United States $1.162B 0.00
Aerie Pharmaceuticals (AERI) United States $1.159B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.048B 3.77
Radius Health (RDUS) United States $1.014B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.983B 0.00
Endo (ENDP) Ireland $0.893B 1.44
Spectrum Pharmaceuticals (SPPI) United States $0.887B 0.00
Concordia (CXRXF) Canada $0.719B 0.00
Aptorum Group (APM) China $0.673B 0.00
Organogenesis Holdings (ORGO) United States $0.623B 0.00
TherapeuticsMD (TXMD) United States $0.598B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.583B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.580B 0.00
GlycoMimetics (GLYC) United States $0.555B 0.00
Karyopharm Therapeutics (KPTI) United States $0.511B 0.00
Akebia Therapeutics (AKBA) United States $0.503B 0.00
Translate Bio (TBIO) United States $0.499B 0.00
ChemoCentryx (CCXI) United States $0.479B 0.00
Siga Technologies (SIGA) United States $0.469B 1.11
Dermira (DERM) United States $0.462B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.460B 23.19
Dova Pharmaceuticals (DOVA) United States $0.453B 0.00
Flexion Therapeutics (FLXN) United States $0.435B 0.00
CannTrust Holdings (CTST) Canada $0.432B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.422B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.420B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.420B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.407B 0.00
CV Sciences (CVSI) United States $0.405B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.397B 0.00
Indivior (INVVY) United States $0.393B 1.42
Collegium Pharmaceutical (COLL) United States $0.375B 0.00
ImmunoGen (IMGN) United States $0.371B 0.00
Innate Pharma SA (IPHYF) France $0.369B 0.00
Harpoon Therapeutics (HARP) United States $0.366B 0.00
Xeris Pharmaceuticals (XERS) United States $0.322B 0.00
OptiNose (OPTN) United States $0.304B 0.00
Rafael Holdings (RFL) United States $0.299B 0.00
KalVista Pharmaceuticals (KALV) United States $0.293B 0.00
Concert Pharmaceuticals (CNCE) United States $0.272B 0.00
Molecular Templates (MTEM) United States $0.264B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.250B 0.00
Aratana Therapeutics (PETX) United States $0.248B 0.00
Lannett Co Inc (LCI) United States $0.229B 2.23
Ocular Therapeutix (OCUL) United States $0.227B 0.00
Recro Pharma (REPH) United States $0.225B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.224B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.211B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.174B 0.00
Calithera Biosciences (CALA) United States $0.174B 0.00
Redhill Biopharma (RDHL) Israel $0.173B 0.00
IMV INC (IMV) Canada $0.170B 0.00
Nature's Sunshine Products (NATR) United States $0.167B 54.00
Taiwan Liposome (TLC) Taiwan $0.164B 0.00
Ardelyx (ARDX) United States $0.159B 0.00
MEI Pharma (MEIP) United States $0.150B 0.00
Jounce Therapeutics (JNCE) United States $0.141B 0.00
Majesco Entertainment (PTE) United States $0.141B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.139B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.124B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.122B 0.00
AgeX Therapeutics (AGE) United States $0.113B 0.00
DURECT (DRRX) United States $0.111B 0.00
Champions Oncology (CSBR) United States $0.104B 0.00
Aquestive Therapeutics (AQST) United States $0.104B 0.00
Generex Biotechnology (GNBT) United States $0.099B 0.00
Infinity Pharmaceuticals (INFI) United States $0.096B 0.00
Capnia (SLNO) United States $0.095B 0.00
RENEURON GP (RNUGF) United Kingdom $0.094B 0.00
Mast Therapeutics (SVRA) United States $0.094B 0.00
Iterum Therapeutics (ITRM) Ireland $0.094B 0.00
Genocea Biosciences (GNCA) United States $0.093B 0.00
Aclaris Therapeutics (ACRS) United States $0.092B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.089B 63.89
MediWound (MDWD) Israel $0.085B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.084B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.083B 0.00
Natural Alternatives (NAII) United States $0.083B 8.27
Avadel Pharmaceuticals (AVDL) Ireland $0.082B 0.00
Nivalis Therapeutics (ALPN) United States $0.078B 0.00
Otonomy (OTIC) United States $0.077B 0.00
China SXT Pharmaceuticals (SXTC) China $0.077B 0.00
Novan (NOVN) United States $0.075B 0.00
Pharmaxis (PXSLY) Australia $0.071B 0.00
Neos Therapeutics (NEOS) United States $0.071B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.069B 0.00
SCYNEXIS (SCYX) United States $0.067B 0.00
India Globalization Capital (IGC) United States $0.060B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.059B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.053B 0.00